Factor Bioscience Celebrates 10th Anniversary with Grand Opening of ISO Class 7 Cleanroom Facility in Cambridge, Massachusetts

September 9, 2021

CAMBRIDGE, Mass., Sept. 15, 2021 /PRNewswire/ — Factor Bioscience Inc., a biotechnology company headquartered in Cambridge, Massachusetts, celebrated its tenth anniversary on September 9, 2021, with the grand opening of its new ISO Class 7 cleanroom facility at its headquarters near Inman Square. The new facility allows Factor and its strategic partners to produce advanced mRNA, gene-editing, and cell-therapy products for all phases of clinical development.

“This expansion will accelerate the development of important therapeutic applications of our technologies in areas such as anti-inflammatory, anti-cancer, and regenerative medicine” said Factor Co-Founder, Chairman, and CEO, Matt Angel, Ph.D. “This is the culmination of a decade of work by the Factor team and a shared vision between us and our strategic partners.”

Pictured from left to right: Howard Federoff, M.D., Ph.D., CEO of Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX); Christopher Rohde, Ph.D., Co-Founder and Chief Technology Officer of Factor Bioscience Inc.; Gregory Fiore, M.D., Co-Founder and CEO of Exacis Biotherapeutics Inc.; Matt Angel, Ph.D., Co-Founder, Chairman, and CEO of Factor Bioscience Inc.